Jakob Skjold-Joergensen

Title: Innovations of Jakob Skjold-Joergensen

Introduction

Jakob Skjold-Joergensen is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of lipase variants. With a total of 2 patents to his name, his work has implications for various applications, including cleaning processes.

Latest Patents

Jakob's latest patents focus on lipase variants and the polynucleotides encoding them. One of his inventions relates to a variant of a parent lipase, which has at least 60% but less than 100% sequence identity with SEQ ID NO: 2. This variant exhibits lipase activity and includes specific substitutions at designated positions while remaining unaltered at others. Additionally, he has developed isolated lipase variants that comprise substitutions at various positions of the mature polypeptide of SEQ ID NO: 2, which also demonstrate lipase activity. His inventions encompass polynucleotides encoding these variants, nucleic acid constructs, vectors, and host cells, along with methods for utilizing these lipase variants in cleaning applications.

Career Highlights

Jakob Skjold-Joergensen is associated with Novozymes A/S, a leading company in the biotechnology sector. His work at Novozymes has allowed him to focus on innovative solutions that enhance the efficiency of cleaning processes through the use of lipase variants.

Collaborations

Jakob has collaborated with notable colleagues such as Jesper Vind and Allan Svendsen. Their combined expertise contributes to the advancement of biotechnological innovations within their field.

Conclusion

Jakob Skjold-Joergensen's contributions to the development of lipase variants highlight his role as an influential inventor in biotechnology. His patents reflect a commitment to innovation that has the potential to impact various industries positively.